Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
97
-
Total 13F shares, excl. options
-
34.2M
-
Shares change
-
+1.6M
-
Total reported value, excl. options
-
$505M
-
Value change
-
+$23.5M
-
Put/Call ratio
-
0.95
-
Number of buys
-
42
-
Number of sells
-
-47
-
Price
-
$14.76
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q3 2020
119 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q3 2020.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.2M shares
of 86.6M outstanding shares and own 39.55% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (3.33M shares), BVF INC/IL (2.47M shares), BOXER CAPITAL, LLC (2.29M shares), BlackRock Inc. (1.88M shares), Avidity Partners Management LP (1.85M shares), MPM ASSET MANAGEMENT LLC (1.84M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.7M shares), VANGUARD GROUP INC (1.4M shares), Nantahala Capital Management, LLC (1.34M shares), and FRAZIER MANAGEMENT LLC (1.32M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.